Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19

A 48-year-old female patient underwent a heart transplantation for acute fulminant myocarditis, following heterologous vaccination with the ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19. She had no history of severe acute respiratory syndrome coronavirus-2 infection. She did not exhibit clinical sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Dong-Hoon, Na, Joo-Young, Yang, Jun-Ho, Moon, Seong-Ho, Kim, Sung-Hwan, Jung, Jae-Jun, Cha, Ho-Jeong, Ahn, Jong-Hwa, Park, Yong-Whi, Cho, Sang-Yeong, Yu, Ho-Kyung, Lee, Soo-Hee, Park, Mi-Yeong, Kim, Jong-Woo, Byun, Joung-Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950462/
https://www.ncbi.nlm.nih.gov/pubmed/35334625
http://dx.doi.org/10.3390/medicina58030449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950462/
https://www.ncbi.nlm.nih.gov/pubmed/35334625
http://dx.doi.org/10.3390/medicina58030449

Ejemplares similares